Navigation Links
Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis

The sad part in the treatment of certain cancers, hepatitis and multiple sclerosis with interferon therapy is that while the treatment can extent life, it can seriously spoil its quality. Alpha interferon a drug used to fight these diseases can cause crippling depression.

A new research now shows that the use of an antidepressant before starting the treatment can avoid this problem. Almost 50% of people on chemotherapy with high dose interferon for skin cancer (malignant melanoma), developed severe depression. But when they were given antidepressant Paxil for two weeks before chemotherapy, only 11% developed depression.

Dr. Andrew H. Miller, MD of the department of psychiatry and behavioral science at Emory University School of Medicine in Atlanta, says doctors have assumed for years that depression therapies themselves can induce depression.

The good news is that Paxil and other antidepressants not only help alleviate the depression that could cause people to stop treatment, but also help in other ways. Study participants who took Paxil before undergoing 12 weeks of interferon treatment reported less pain and fewer instances of gastric irritations. They also reported less confusion or memory problems and slightly less fatigue than people who didn’t get the antidepressants
'"/>




Page: 1

Related medicine news :

1. Antidepressants increase gastric bleeding
2. Antidepressants-important role
3. Antidepressants increase gastric bleeding
4. Antidepressants could pose grave implications
5. Antidepressants May Benefit Heart Patients
6. Antidepressants Harmful for Kids
7. Antidepressants For Children: How safe is it ?
8. Antidepressants Late In Pregnancy Harmful to Unborn Baby
9. Antidepressants Could Lead To Abnormal Bleeding
10. Young Patients On Antidepressants Found To Be Associated With Suicidal Tendencies
11. Antidepressants linked to reduced risk of heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: